Seven biotechs led the way.
News & Analysis: Kodiak Sciences Inc
These stocks have soared 935% or more this year. Can they keep the momentum going?
Here's why these drugmaker stocks are the year's top performers.
Helping people stricken with illness can be richly rewarding in more ways than one.
These clinical-stage biotech stocks have delivered eye-popping gains in 2019, but what about the road ahead?
These stocks helped lead the markets higher.
Momentum continues from the drugmaker's royalty deal announced earlier this week despite a big public stock offering.
On a bad day on Wall Street, these stocks still held up well.
Investors are excited about a big royalty deal for the biotech's lead pipeline candidate.
Despite soaring already, these biotech stocks aren't finished climbing.